Cargando…
Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation
BACKGROUND: Epicardial adipose tissue (EAT) secretome induces fibrosis. Fibrosis, primarily extracellular matrix (ECM) produced by fibroblasts, creates a substrate for atrial fibrillation (AF). Whether the EAT secretome from patients with AF activates human atrial fibroblasts and through which compo...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245533/ https://www.ncbi.nlm.nih.gov/pubmed/37280612 http://dx.doi.org/10.1186/s12967-023-04231-2 |
_version_ | 1785054881998962688 |
---|---|
author | Meulendijks, Eva R. Al-Shama, Rushd F. M. Kawasaki, Makiri Fabrizi, Benedetta Neefs, Jolien Wesselink, Robin Ernault, Auriane C. Piersma, Sander Pham, Thang V. Jimenez, Connie R. Knol, Jaco C. van Boven, Wim J. P. Driessen, Antoine H. G. de Vries, Tim A. C. van der Leeden, Britt Niessen, Hans W. M. de Boer, Onno J. Krul, Sébastien P. J. de Groot, Joris R. |
author_facet | Meulendijks, Eva R. Al-Shama, Rushd F. M. Kawasaki, Makiri Fabrizi, Benedetta Neefs, Jolien Wesselink, Robin Ernault, Auriane C. Piersma, Sander Pham, Thang V. Jimenez, Connie R. Knol, Jaco C. van Boven, Wim J. P. Driessen, Antoine H. G. de Vries, Tim A. C. van der Leeden, Britt Niessen, Hans W. M. de Boer, Onno J. Krul, Sébastien P. J. de Groot, Joris R. |
author_sort | Meulendijks, Eva R. |
collection | PubMed |
description | BACKGROUND: Epicardial adipose tissue (EAT) secretome induces fibrosis. Fibrosis, primarily extracellular matrix (ECM) produced by fibroblasts, creates a substrate for atrial fibrillation (AF). Whether the EAT secretome from patients with AF activates human atrial fibroblasts and through which components, remains unexplored. RESEARCH AIMS: (a) To investigate if the EAT secretome from patients with versus without AF increases ECM production in atrial fibroblasts. (b) To identify profibrotic proteins and processes in the EAT secretome and EAT from patients with, who will develop (future onset), and without AF. METHODS: Atrial EAT was obtainded during thoracoscopic ablation (AF, n = 20), or open-heart surgery (future onset and non-AF, n = 35). ECM gene expression of human atrial fibroblasts exposed to the EAT secretome and the proteomes of EAT secretome and EAT were assessed in patients with and without AF. Myeloperoxidase and neutrophil extracellular traps (NETs) were assessed immunohistochemically in patients with paroxysmal, persistent, future onset, and those who remain free of AF (non-AF). RESULTS: The expression of COL1A1 and FN1 in fibroblasts exposed to secretome from patients with AF was 3.7 and 4.7 times higher than in patients without AF (p < 0.05). Myeloperoxidase was the most increased protein in the EAT secretome and EAT from patients with versus without AF (FC 18.07 and 21.57, p < 0.005), as was the gene-set neutrophil degranulation. Immunohistochemically, myeloperoxidase was highest in persistent (FC 13.3, p < 0.0001) and increased in future onset AF (FC 2.4, p = 0.02) versus non-AF. Myeloperoxidase aggregated subepicardially and around fibrofatty infiltrates. NETs were increased in patients with persistent versus non-AF (p = 0.03). CONCLUSION: In AF, the EAT secretome induces ECM gene expression in atrial fibroblasts and contains abundant myeloperoxidase. EAT myeloperoxidase was increased prior to AF onset, and both myeloperoxidase and NETs were highest in persistent AF, highlighting the role of EAT neutrophils in the pathophysiology of AF. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04231-2. |
format | Online Article Text |
id | pubmed-10245533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102455332023-06-08 Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation Meulendijks, Eva R. Al-Shama, Rushd F. M. Kawasaki, Makiri Fabrizi, Benedetta Neefs, Jolien Wesselink, Robin Ernault, Auriane C. Piersma, Sander Pham, Thang V. Jimenez, Connie R. Knol, Jaco C. van Boven, Wim J. P. Driessen, Antoine H. G. de Vries, Tim A. C. van der Leeden, Britt Niessen, Hans W. M. de Boer, Onno J. Krul, Sébastien P. J. de Groot, Joris R. J Transl Med Research BACKGROUND: Epicardial adipose tissue (EAT) secretome induces fibrosis. Fibrosis, primarily extracellular matrix (ECM) produced by fibroblasts, creates a substrate for atrial fibrillation (AF). Whether the EAT secretome from patients with AF activates human atrial fibroblasts and through which components, remains unexplored. RESEARCH AIMS: (a) To investigate if the EAT secretome from patients with versus without AF increases ECM production in atrial fibroblasts. (b) To identify profibrotic proteins and processes in the EAT secretome and EAT from patients with, who will develop (future onset), and without AF. METHODS: Atrial EAT was obtainded during thoracoscopic ablation (AF, n = 20), or open-heart surgery (future onset and non-AF, n = 35). ECM gene expression of human atrial fibroblasts exposed to the EAT secretome and the proteomes of EAT secretome and EAT were assessed in patients with and without AF. Myeloperoxidase and neutrophil extracellular traps (NETs) were assessed immunohistochemically in patients with paroxysmal, persistent, future onset, and those who remain free of AF (non-AF). RESULTS: The expression of COL1A1 and FN1 in fibroblasts exposed to secretome from patients with AF was 3.7 and 4.7 times higher than in patients without AF (p < 0.05). Myeloperoxidase was the most increased protein in the EAT secretome and EAT from patients with versus without AF (FC 18.07 and 21.57, p < 0.005), as was the gene-set neutrophil degranulation. Immunohistochemically, myeloperoxidase was highest in persistent (FC 13.3, p < 0.0001) and increased in future onset AF (FC 2.4, p = 0.02) versus non-AF. Myeloperoxidase aggregated subepicardially and around fibrofatty infiltrates. NETs were increased in patients with persistent versus non-AF (p = 0.03). CONCLUSION: In AF, the EAT secretome induces ECM gene expression in atrial fibroblasts and contains abundant myeloperoxidase. EAT myeloperoxidase was increased prior to AF onset, and both myeloperoxidase and NETs were highest in persistent AF, highlighting the role of EAT neutrophils in the pathophysiology of AF. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04231-2. BioMed Central 2023-06-06 /pmc/articles/PMC10245533/ /pubmed/37280612 http://dx.doi.org/10.1186/s12967-023-04231-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Meulendijks, Eva R. Al-Shama, Rushd F. M. Kawasaki, Makiri Fabrizi, Benedetta Neefs, Jolien Wesselink, Robin Ernault, Auriane C. Piersma, Sander Pham, Thang V. Jimenez, Connie R. Knol, Jaco C. van Boven, Wim J. P. Driessen, Antoine H. G. de Vries, Tim A. C. van der Leeden, Britt Niessen, Hans W. M. de Boer, Onno J. Krul, Sébastien P. J. de Groot, Joris R. Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation |
title | Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation |
title_full | Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation |
title_fullStr | Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation |
title_full_unstemmed | Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation |
title_short | Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation |
title_sort | atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245533/ https://www.ncbi.nlm.nih.gov/pubmed/37280612 http://dx.doi.org/10.1186/s12967-023-04231-2 |
work_keys_str_mv | AT meulendijksevar atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT alshamarushdfm atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT kawasakimakiri atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT fabrizibenedetta atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT neefsjolien atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT wesselinkrobin atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT ernaultaurianec atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT piersmasander atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT phamthangv atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT jimenezconnier atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT knoljacoc atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT vanbovenwimjp atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT driessenantoinehg atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT devriestimac atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT vanderleedenbritt atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT niessenhanswm atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT deboeronnoj atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT krulsebastienpj atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation AT degrootjorisr atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation |